Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hypertrophic Cardiomyopathy Extended Panel Health in Code Spain | 1 | 90 |
|
Hypertrophic Cardiomyopathy Short Panel Health in Code Spain | 1 | 16 |
|
Pan Cardiomyopathy Panel (62 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 101 | 61 |
|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
CAV3 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 5 | 1 |
|
MYH7 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 6 | 1 |
|
MYLK2 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
CAV3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
MYH7 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 6 | 1 |
|
MYLK2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
Nonsyndromic Congenital Heart Disease Panel PreventionGenetics United States | 54 | 44 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Cardiomyopathy, hypertrophic, 1, 192600, Autosomal dominant (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Cardiomyopathy, familial hypertrophic, 192600, Autosomal dominant (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 482 | 254 |
|
Invitae 59 Gene Actionable Disorders Panel Invitae United States | 57 | 59 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.